Form 8-K - Current report:
SEC Accession No. 0000944809-21-000006
Filing Date
2021-02-01
Accepted
2021-02-01 16:16:06
Documents
14
Period of Report
2021-02-01
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K opk-20210201.htm   iXBRL 8-K 35602
  Complete submission text file 0000944809-21-000006.txt   176733

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opk-20210201.xsd EX-101.SCH 2448
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT opk-20210201_cal.xml EX-101.CAL 740
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT opk-20210201_def.xml EX-101.DEF 1686
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT opk-20210201_lab.xml EX-101.LAB 24275
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opk-20210201_pre.xml EX-101.PRE 12676
7 EXTRACTED XBRL INSTANCE DOCUMENT opk-20210201_htm.xml XML 10758
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4181
OPKO HEALTH, INC. (Filer) CIK: 0000944809 (see all company filings)

EIN.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33528 | Film No.: 21576876
SIC: 2834 Pharmaceutical Preparations